NASDAQ:SWAV
Delisted

Shockwave Medical Stock News

etoro logo Buy SWAV
*Your capital is at risk
$334.75
+0 (+0%)
At Close: Aug 29, 2024
ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.
Investors need to pay close attention to Shockwave Medical (SWAV) stock based on the movements in the options market lately.
Shockwave Medical's (SWAV) latest U.S. launch is expected to serve a wider patient pool.
ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.
Palo Alto Networks stands to benefit from increasing demand for single-vendor security solutions. Duolingo has differentiated itself from the competition by making language learning fun and engaging.

5 Big Earning Beats Making These Stocks a Buy

03:03pm, Thursday, 23'rd Feb 2023
When a company beats earnings estimates, investors often pile into it. But not all earnings beats are created equal.
ShockWave is a high margin and fast grower with a large addressable market. ShockWave is profitable with good cost controls, unlike many other technology peers that are growing at a breakneck pace.
This up-and-coming medical technology star is set up to deliver market-beating gains for its long-term investors.
Two new Breakout Stocks for Week 8 with better than 10% short-term upside and two Dow 30 Picks. Average cumulative returns for 2023 are +36.7% YTD. This week peak gains were in INDI +22.83% and LTRX +
Shockwave Medical tripled Wall Street's fourth-quarter profitability expectations, leading SWAV stock to surge on Friday. The post Shockwave Medical Just Tripled Profit Expectations, Delivering 991% G
Shockwave Medical's (SWAV) fourth-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.
ShockWave Medical, Inc. (NASDAQ:SWAV ) Q4 2022 Earnings Conference Call February 16, 2023 4:30 PM ET Company Participants Debbie Kaster - VP, IR Doug Godshall - President and CEO Isaac Zacharias - Pre
Shockwave Medical (SWAV) delivered earnings and revenue surprises of 274.75% and 1.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

3 Mid-Cap Earnings Plays to Watch This Week

04:08am, Tuesday, 14'th Feb 2023
With the U.S. economy teetering towards a recession, Wall Street's estimates for corporate earnings have been trending lower. On the bright side, this could create more opportunities for traders to ga
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE